Geode Capital Management LLC Acquires 173,796 Shares of Metagenomi, Inc. (NASDAQ:MGX)

Geode Capital Management LLC lifted its holdings in Metagenomi, Inc. (NASDAQ:MGX - Free Report) by 105.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 338,031 shares of the company's stock after acquiring an additional 173,796 shares during the period. Geode Capital Management LLC owned approximately 0.90% of Metagenomi worth $734,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of MGX. Rhumbline Advisers bought a new position in Metagenomi during the 2nd quarter worth $26,000. Resolute Advisors LLC grew its holdings in shares of Metagenomi by 165.0% during the 2nd quarter. Resolute Advisors LLC now owns 26,500 shares of the company's stock worth $108,000 after purchasing an additional 16,500 shares in the last quarter. XTX Topco Ltd bought a new position in shares of Metagenomi in the second quarter worth $66,000. Novo Holdings A S raised its stake in Metagenomi by 3.5% in the second quarter. Novo Holdings A S now owns 1,800,000 shares of the company's stock valued at $7,344,000 after purchasing an additional 60,825 shares in the last quarter. Finally, Green Alpha Advisors LLC acquired a new position in Metagenomi in the third quarter valued at about $69,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Chardan Capital reaffirmed a "buy" rating and issued a $15.00 target price on shares of Metagenomi in a report on Wednesday, November 20th. HC Wainwright upped their price objective on Metagenomi from $7.00 to $14.00 and gave the stock a "buy" rating in a research report on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $16.67.

Metagenomi Stock Up 1.3 %

Shares of Metagenomi stock traded up $0.04 on Friday, hitting $3.13. 503,415 shares of the company's stock traded hands, compared to its average volume of 732,886. The company has a fifty day moving average of $2.79 and a two-hundred day moving average of $2.99. Metagenomi, Inc. has a one year low of $1.61 and a one year high of $12.74.

Metagenomi Company Profile

Metagenomi, Inc, a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases.